SUBSCRIBE
SUBSCRIBE

Rheos Medicines, Inc.

NEWS
Rheos Medicines, Inc. is no longer in business.
Blood sample tube for interleukin 6 or IL-6 test, Pro-inflammatory cytokine and anti-inflammatory myokine
The Rise and Expansion of Cytokine-based Therapy
Some cytokines can stimulate the immune system, while others slow it down. Here’s a look at the latest news on cytokine data and therapy developments.
May 9, 2022
 · 
4 min read
 · 
Mark Terry
Business
Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
November 6, 2018
 · 
12 min read
 · 
Mark Terry
IN THE PRESS
Business
Rheos Medicines CSO Dania Rabah to Deliver Keynote Address at AAPS National Biotechnology Conference
May 12, 2022
 · 
2 min read
Drug Development
Rheos Medicines Announces Publication of New Data to Support Targeting MALT1 to Treat Autoimmune and Inflammatory Diseases
May 9, 2022
 · 
5 min read
Business
Rheos Medicines Announces New Scientific Advisory Board Members
April 14, 2022
 · 
5 min read
Business
Rheos Medicines Appoints Katerina Leftheris, Ph.D., as SVP of Drug Discovery and Nabil Uddin, Pharm.D., as VP of Strategy and Business Development
April 14, 2022
 · 
5 min read
Drug Development
Rheos Medicines Presents New Data Supporting MALT1 Inhibition as Novel Strategy for Precision Medicine-Based Approach to Treating Chronic Graft-Versus-Host Disease
December 13, 2021
 · 
4 min read
Genetown
Rheos Medicines to Participate in the 2021 RBC Capital Markets Healthcare Private Company Conference
December 9, 2021
 · 
1 min read
Genetown
Rheos Medicines to Present Data at ASH 2021 for MALT1 Inhibition for Treatment of Graft-Versus-Host Disease
November 4, 2021
 · 
3 min read
Drug Development
Rheos Medicines Presents Data Demonstrating Potential of MALT1 Inhibition as Novel Approach for the Treatment of Autoimmune and Inflammatory Diseases
November 1, 2021
 · 
6 min read
Genetown
Rheos Medicines to Present Data at ACR 2021 for MALT1 Inhibitors in Autoimmune and Inflammatory Disease and Announces RHX-317 as First Development Candidate
October 13, 2021
 · 
6 min read
Business
Rheos Medicines Appoints Nirupama Subramanian as Chief Operating Officer
August 9, 2021
 · 
4 min read
Load More
AWARDS
  • NextGen Class of 2019
JOBS